OncoCyte Corporation OCX
3.20 0.00 (+0.00%)
At closeJun 17, 2025, 4:00 PM EDT
2.82 Day range 3.20
52-week range unavailable
- YTD
- +34.45%
- 1 year
- +15.94%
Revenue & Expenses
Latest period ending Dec 31, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 1.88M | 1.50M | 958.00K | 2.20M | 1.22M | |
| 740.00K | 413.00K | -18.00K | 1.42M | -639.00K | |
| -61.04M | -25.14M | -18.00M | -53.73M | -29.71M | |
| -60.93M | -28.72M | -72.90M | -64.10M | -29.93M | |
| -4.66 | -3.75 | -13.25 | -14.40 | -9.20 |
Balance sheet
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 10.34M | 11.13M | 21.69M | 34.65M | 8.84M | |
| 35.08M | 74.89M | 100.09M | 159.56M | 55.42M | |
| 47.35M | 49.30M | 60.50M | 94.35M | 21.94M | |
| 3.66M | 2.87M | 3.54M | 5.68M | 8.63M | |
| -12.27M | 20.47M | 34.29M | 65.22M | 33.48M |
Cash flow
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| -20.71M | -23.32M | -45.57M | -35.94M | -25.98M | |
| -512.00K | -932.00K | -4.34M | -13.96M | -11.75M | |
| 20.43M | 12.19M | 35.81M | 78.36M | 22.80M | |
| -512.00K | 73.00K | -4.34M | -2.25M | -1.23M | |
| -796.00K | -12.07M | -14.10M | 28.46M | -14.93M |